JasonWenChienMD
Pulmonology • Seattle, WACritical Care Medicine, Infectious Disease, Pleural Disease
Associate Professor, Medicine, University of Washington School of Medicine
Are you Dr. Chien?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 49 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Ambulatory Clinic
825 Eastlake Avenue East
Seattle, WA 98109Phone+1 206-288-1000
Summary
- Dr. Jason Chien, MD is a pulmonologist in Seattle, Washington. He is currently licensed to practice medicine in Washington and Ohio. He is affiliated with UW Medicine/University of Washington Medical Center and is an Associate Professor at University of Washington School of Medicine.
Education & Training
University of WashingtonFellowship, Pulmonary Disease and Critical Care Medicine, 1999 - 2002
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Infectious Disease, 1997 - 1999- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1994 - 1997
Rutgers New Jersey Medical SchoolClass of 1994
Certifications & Licensure
WA State Medical License 1999 - 2026
OH State Medical License 1996 - 2001
Publications & Presentations
PubMed
- 44 citationsA Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hemat...Roy F. Chemaly, Sanjeet Dadwal, Anne Bergeron, Per Ljungman, Yae Jean Kim
Clinical Infectious Diseases. 2020-12-31 - 46 citationsA Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in He...Francisco M. Marty, Roy F. Chemaly, Kathleen M. Mullane, Dong-Gun Lee, Hans H. Hirsch
Clinical Infectious Diseases. 2020-12-31 - 16 citationsDrug Resistance Assessment Following Administration of Respiratory Syncytial Virus (RSV) Fusion Inhibitor Presatovir to Participants Experimentally Infected With RSV.Kirsten M. Stray, Michel Perron, Danielle P. Porter, Francisco Anderson, Sandra A Lewis
The Journal of Infectious Diseases. 2020-10-01
Grant Support
- Biomarkers And Targeted Therapy Of Bronchiolitis ObliteransNational Cancer Institute2011
- Biomarkers And Targeted Therapy Of Bronchiolitis ObliteransNational Institute Of Allergy And Infectious Diseases2009–2010
- Genetic Analysis Of Airflow Obstruction After Stem Cell TransplantationNational Heart, Lung, And Blood Institute2008–2009
- Genetic Epidemiology Of TLR4 Alleles And BacteremiaNational Heart, Lung, And Blood Institute2002–2006
